See other bills
under the
same topic
        PRIOR PRINTER'S NO. 2308                      PRINTER'S NO. 3690

THE GENERAL ASSEMBLY OF PENNSYLVANIA


HOUSE BILL

No. 1730 Session of 2007


        INTRODUCED BY BLACKWELL, PARKER, SHIMKUS, BRENNAN, KIRKLAND,
           JAMES, DePASQUALE, YOUNGBLOOD, MURT, SIPTROTH, HENNESSEY,
           CURRY, JOSEPHS, BOYD, MUNDY, PALLONE AND SWANGER,
           JULY 13, 2007

        AS REPORTED FROM COMMITTEE ON HEALTH AND HUMAN SERVICES, HOUSE
           OF REPRESENTATIVES, AS AMENDED, MAY 5, 2008

                                     AN ACT

     1  Prohibiting use of coercion and undue influence to gain           <--
     2     participation of special needs persons in certain research;
     3     and imposing a penalty.
     4  REQUIRING THE DEPARTMENT OF HEALTH TO ESTABLISH STANDARDS         <--
     5     GOVERNING PROTECTIONS FOR HUMAN SUBJECTS OF RESEARCH IN THIS
     6     COMMONWEALTH; AND REQUIRING RESEARCHERS TO OBTAIN LEGALLY
     7     EFFECTIVE INFORMED CONSENT FROM EACH RESEARCH SUBJECT OR THE
     8     SUBJECT'S LEGALLY AUTHORIZED REPRESENTATIVE.

     9     The General Assembly of the Commonwealth of Pennsylvania
    10  hereby enacts as follows:
    11  Section 1.  Short title.                                          <--
    12     This act shall be known and may be cited as the Research
    13  Consent Act.
    14  Section 2.  Definitions.
    15     The following words and phrases when used in this act shall
    16  have the meanings given to them in this section unless the
    17  context clearly indicates otherwise:
    18     "Interaction."  Includes communication and interpersonal
    19  contact between an investigator and a subject.


     1     "Intervention."  Includes physical procedures by which data
     2  are gathered and manipulations of the subject's environment that
     3  are performed for research purposes.
     4     "Investigator."  A person conducting research directly or
     5  indirectly on behalf of any organization conducting
     6  experimentation upon humans including, but not limited to,
     7  pharmaceutical companies, universities, hospitals, whether
     8  public or private, and governmental entities.
     9     "Poor."  An individual whose personal or family income falls
    10  below two times the poverty level.
    11     "Private information."  Includes individually identifiable
    12  information about behavior that occurs in a context in which an
    13  individual can reasonably expect that no observation or
    14  recording is taking place and individually identifiable
    15  information provided for specific purposes by an individual
    16  which the individual can reasonably expect will not be made
    17  public.
    18     "Research."  A systematic investigation designed to develop
    19  or contribute to generalized knowledge. The term includes, but
    20  is not limited to, generalized research, development, testing
    21  and evaluation.
    22     "Special needs person."  An individual who suffers from a
    23  developmental disability, is mentally ill or poor, has substance
    24  abuse intervention issues or has been convicted of a felony and
    25  served time in prison as a result of committing the felony.
    26     "Subject."  A living individual about whom an investigator,
    27  whether professional or student, conducting research obtains:
    28         (1)  data through intervention or interaction with the
    29     individual; or
    30         (2)  identifiable private information.
    20070H1730B3690                  - 2 -     

     1  Section 3.  Undue influence and coercion prohibited.
     2     No investigator may involve a special needs individual as a
     3  subject in research unless the investigator has obtained the
     4  informed consent of the subject or the subject's legally
     5  authorized representative in accordance with the provisions of
     6  this act. An investigator shall seek consent only under
     7  circumstances that provide the prospective subject or
     8  representative sufficient opportunity to consider whether or not
     9  to participate and minimize the possibility of coercion or undue
    10  influence. Information given to the subject or representative
    11  shall be in language understandable to the subject or
    12  representative. No consent or consent form, whether oral or
    13  written, may include exculpatory language through which the
    14  subject or representative waives or appears to waive a legal
    15  right or releases or appears to release the investigator,
    16  sponsor, institution or an agent from liability for negligence.
    17  Section 4.  Penalty.
    18     A violation of any provision of this act constitutes a felony
    19  of the third degree.
    20  Section 5.  Effective date.
    21     This act shall take effect in 60 days.
    22  SECTION 1.  SHORT TITLE.                                          <--
    23     THIS ACT SHALL BE KNOWN AND MAY BE CITED AS THE PROTECTIONS
    24  FOR HUMAN SUBJECTS OF RESEARCH ACT.
    25  SECTION 2.  DEFINITIONS.
    26     THE FOLLOWING WORDS AND PHRASES WHEN USED IN THIS ACT SHALL
    27  HAVE THE MEANINGS GIVEN TO THEM IN THIS SECTION UNLESS THE
    28  CONTEXT CLEARLY INDICATES OTHERWISE:
    29     "DEPARTMENT."  THE DEPARTMENT OF HEALTH OF THE COMMONWEALTH.
    30     "HUMAN RESEARCH SUBJECT."  A LIVING INDIVIDUAL ABOUT WHOM AN
    20070H1730B3690                  - 3 -     

     1  INVESTIGATOR CONDUCTING RESEARCH OBTAINS DATA THROUGH
     2  INTERVENTION OR INTERACTION.
     3     "INFORMED CONSENT."  THE PROCESS OF PROVIDING THE KEY FACTS
     4  ABOUT RESEARCH BEFORE HUMAN RESEARCH SUBJECTS DECIDE WHETHER OR
     5  NOT TO PARTICIPATE. IT IS ALSO A CONTINUING PROCESS THROUGHOUT
     6  THE RESEARCH TO PROVIDE INFORMATION TO HELP HUMAN RESEARCH
     7  SUBJECTS DECIDE WHETHER OR NOT TO CONTINUE PARTICIPATION.
     8  INFORMED CONSENT MUST BE SOUGHT UNDER CIRCUMSTANCES THAT
     9  MINIMIZE THE POSSIBILITY OF COERCION OF UNDUE INFLUENCE.
    10     "INVESTIGATOR."  A PERSON CONDUCTING RESEARCH ON BEHALF OF
    11  ANY ORGANIZATION CONDUCTING RESEARCH, INCLUDING, BUT NOT LIMITED
    12  TO, PHARMACEUTICAL COMPANIES, UNIVERSITIES, HOSPITALS AND
    13  GOVERNMENT ENTITIES.
    14     "RESEARCH."  A SYSTEMATIC INVESTIGATION, INCLUDING
    15  DEVELOPMENT, TESTING AND EVALUATION DESIGNED TO DEVELOP OR
    16  CONTRIBUTE TO GENERALIZED KNOWLEDGE. ACTIVITIES WHICH MEET THIS
    17  DEFINITION CONSTITUTE RESEARCH FOR PURPOSES OF THIS ACT, WHETHER
    18  OR NOT THEY ARE SUPPORTED UNDER A PROGRAM WHICH IS CONSIDERED
    19  RESEARCH FOR OTHER PURPOSES.
    20  SECTION 3.  DEPARTMENT.
    21     (A)  ADOPTION OF STANDARD.--WITHIN SIX MONTHS OF THE
    22  EFFECTIVE DATE OF THIS ACT, THE DEPARTMENT SHALL ADOPT A
    23  PROTECTIONS FOR HUMAN SUBJECTS OF RESEARCH STANDARD. THE
    24  STANDARD SHALL BE AT LEAST AS PRESCRIPTIVE AS THE STANDARD
    25  PROMULGATED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES AND
    26  SHALL INCLUDE THE FOLLOWING, EXCEPT IN CASES WHERE THE
    27  DEPARTMENT SPECIFICALLY APPROVES A WAIVER IN ACCORDANCE WITH
    28  FEDERAL REGULATIONS OR SUBSECTION (D). NO INVESTIGATOR MAY
    29  INVOLVE A HUMAN BEING AS A SUBJECT IN RESEARCH IN THIS
    30  COMMONWEALTH UNLESS THE INVESTIGATOR HAS OBTAINED THE LEGALLY
    20070H1730B3690                  - 4 -     

     1  EFFECTIVE INFORMED CONSENT OF THE HUMAN RESEARCH SUBJECT OR THE
     2  SUBJECT'S LEGALLY AUTHORIZED REPRESENTATIVE. AN INVESTIGATOR
     3  SHALL SEEK SUCH CONSENT ONLY UNDER CIRCUMSTANCES THAT PROVIDE
     4  THE PROSPECTIVE HUMAN RESEARCH SUBJECT OR THE SUBJECT'S
     5  REPRESENTATIVE SUFFICIENT OPPORTUNITY TO CONSIDER WHETHER OR NOT
     6  TO PARTICIPATE AND THAT MINIMIZE THE POSSIBILITY OF COERCION OR
     7  UNDUE INFLUENCE. THE INFORMATION THAT IS GIVEN TO THE HUMAN
     8  RESEARCH SUBJECT OR THE SUBJECT'S REPRESENTATIVE SHALL BE IN
     9  LANGUAGE UNDERSTANDABLE TO THE SUBJECT OR THE SUBJECT'S
    10  REPRESENTATIVE. NO INFORMED CONSENT, WHETHER ORAL OR WRITTEN,
    11  MAY INCLUDE ANY EXCULPATORY LANGUAGE THROUGH WHICH THE HUMAN
    12  RESEARCH SUBJECT OR THE SUBJECT'S REPRESENTATIVE IS MADE TO
    13  WAIVE OR APPEAR TO WAIVE ANY OF THE SUBJECT'S LEGAL RIGHTS OR
    14  RELEASE OR APPEAR TO RELEASE THE INVESTIGATOR, THE SPONSOR, THE
    15  INSTITUTION OR ITS AGENTS FROM LIABILITY FOR NEGLIGENCE.
    16     (B)  INFORMATION REQUIRED.--IN SEEKING INFORMED CONSENT, ALL
    17  OF THE FOLLOWING INFORMATION SHALL BE PROVIDED TO EACH HUMAN
    18  RESEARCH SUBJECT, EXCEPT AS PROVIDED IN SUBSECTION (D):
    19         (1)  A STATEMENT THAT THE STUDY INVOLVES RESEARCH, AN
    20     EXPLANATION OF THE PURPOSES OF THE RESEARCH, THE EXPECTED
    21     DURATION OF THE SUBJECT'S PARTICIPATION, A DESCRIPTION OF THE
    22     PROCEDURES TO BE FOLLOWED AND THE IDENTIFICATION OF ANY
    23     PROCEDURES WHICH ARE EXPERIMENTAL.
    24         (2)  A DESCRIPTION OF ANY REASONABLY FORSEEABLE RISKS OR
    25     DISCOMFORTS TO THE SUBJECT.
    26         (3)  A DESCRIPTION OF ANY BENEFITS TO THE SUBJECT OR TO
    27     OTHERS WHICH MAY REASONABLY BE EXPECTED FROM THE RESEARCH.
    28         (4)  A DISCLOSURE OF APPROPRIATE ALTERNATIVE PROCEDURES
    29     OR COURSES OF TREATMENT, IF ANY, THAT MIGHT BE ADVANTAGEOUS
    30     TO THE SUBJECT.
    20070H1730B3690                  - 5 -     

     1         (5)  A STATEMENT DESCRIBING THE EXTENT, IF ANY, TO WHICH
     2     CONFIDENTIALITY OF RECORDS IDENTIFYING THE SUBJECT WILL BE
     3     MAINTAINED.
     4         (6)  FOR RESEARCH INVOLVING MORE THAN MINIMAL RISK, AN
     5     EXPLANATION AS TO WHETHER ANY COMPENSATION AND ANY MEDICAL
     6     TREATMENTS ARE AVAILABLE IF INJURY OCCURS AND, IF SO, WHAT
     7     THEY CONSIST OF OR WHERE FURTHER INFORMATION MAY BE OBTAINED.
     8         (7)  AN EXPLANATION OF WHOM TO CONTACT FOR ANSWERS TO
     9     PERTINENT QUESTIONS ABOUT THE RESEARCH AND THE SUBJECT'S
    10     RIGHTS, AND WHOM TO CONTACT IN THE EVENT OF A RESEARCH-
    11     RELATED INJURY TO THE SUBJECT.
    12         (8)  A STATEMENT THAT PARTICIPATION IS VOLUNTARY AND THAT
    13     REFUSAL TO PARTICIPATE WILL INVOLVE NO PENALTY OR LOSS OF
    14     BENEFITS TO WHICH THE SUBJECT IS OTHERWISE ENTITLED.
    15     (C)  ADDITIONAL ELEMENTS OF INFORMED CONSENT.--WHEN
    16  APPROPRIATE, ONE OR MORE OF THE FOLLOWING ELEMENTS OF
    17  INFORMATION SHALL ALSO BE PROVIDED TO EACH HUMAN RESEARCH
    18  SUBJECT:
    19         (1)  A STATEMENT THAT THE PARTICULAR TREATMENT OR
    20     PROCEDURE MAY INVOLVE RISKS TO THE SUBJECT OR TO THE EMBRYO
    21     OR FETUS, IF THE SUBJECT IS OR MAY BECOME PREGNANT, WHICH ARE
    22     CURRENTLY UNFORSEEABLE.
    23         (2)  ANTICIPATED CIRCUMSTANCES UNDER WHICH THE SUBJECT'S
    24     PARTICIPATION MAY BE TERMINATED BY THE INVESTIGATOR WITHOUT
    25     REGARD TO THE SUBJECT'S CONSENT.
    26         (3)  ANY ADDITIONAL COSTS TO THE SUBJECT THAT MAY RESULT
    27     FROM PARTICIPATION IN THE RESEARCH.
    28         (4)  THE CONSEQUENCES OF A SUBJECT'S DECISION TO WITHDRAW
    29     FROM THE RESEARCH AND PROCEDURES FOR ORDERLY TERMINATION OF
    30     PARTICIPATION BY THE SUBJECT.
    20070H1730B3690                  - 6 -     

     1         (5)  A STATEMENT THAT SIGNIFICANT NEW FINDINGS DEVELOPED
     2     DURING THE COURSE OF THE RESEARCH MAY RELATE TO THE SUBJECT'S
     3     WILLINGNESS TO CONTINUE PARTICIPATION.
     4         (6)  THE APPROXIMATE NUMBER OF SUBJECTS IN THE STUDY.
     5     (D)  WAIVER.--THE DEPARTMENT MAY APPROVE A CONSENT PROCEDURE
     6  WHICH DOES NOT INCLUDE OR WHICH ALTERS SOME OR ALL OF THE
     7  ELEMENTS OF INFORMED CONSENT SET FORTH IN SUBSECTIONS (B) AND
     8  (C) OR WAIVE THE REQUIREMENT TO OBTAIN INFORMED CONSENT,
     9  PROVIDED THAT:
    10         (1)  THE RESEARCH OR DEMONSTRATION PROJECT IS TO BE
    11     CONDUCTED BY OR SUBJECT TO THE APPROVAL OF STATE OR LOCAL
    12     GOVERNMENT OFFICIALS AND IS DESIGNED TO STUDY, EVALUATE OR
    13     OTHERWISE EXAMINE:
    14             (I)  PUBLIC BENEFIT OR SERVICE PROGRAMS;
    15             (II)  PROCEDURES FOR OBTAINING BENEFITS OR SERVICES
    16         UNDER THOSE PROGRAMS;
    17             (III)  POSSIBLE CHANGES IN OR ALTERNATIVES TO THOSE
    18         PROGRAMS OR PROCEDURES; OR
    19             (IV)  POSSIBLE CHANGES IN METHODS OR LEVELS OF
    20         PAYMENT FOR BENEFITS OR SERVICES UNDER THOSE PROGRAMS.
    21         (2)  THE RESEARCH COULD NOT BE PRACTICABLY CARRIED OUT
    22     WITHOUT THE WAIVER OR ALTERATION.
    23  SECTION 4.  RULES AND REGULATIONS.
    24     THE DEPARTMENT SHALL PROMULGATE RULES AND REGULATIONS AS
    25  NECESSARY TO CARRY OUT THE PROVISIONS OF THIS ACT.
    26  SECTION 5.  EFFECTIVE DATE.
    27     THIS ACT SHALL TAKE EFFECT JULY 1, 2008.


    F18L35RLE/20070H1730B3690        - 7 -